UNSPSC 51422409: Deoxycorticosterone or desoxycorticosterone or desoxycortone

This classification denotes a therapeutic glucocorticoid with the molecular formula C21H30O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 40GP35YQ49, chemically known as 21-hydroxypregn-4-ene-3,20-dione but generally known as deoxycorticosterone, which bears US NIH Compound Identifier 6166. SMILES: CC12CCC3C(C1CCC2C(=O)CO)CCC4=CC(=O)CCC34C.

UNSPSC 51422409 Deoxycorticosterone or desoxycorticosterone or desoxycortone is a Commodity code, but the recent state and local procurement activity indexed under it does not reflect purchases of that pharmaceutical compound. Instead, the opportunities on record show solicitation for naloxone (an opioid reversal agent) and pharmacy benefit management services. The mismatch suggests that either the code assignment is incorrect at the source or the indexed opportunities do not represent the typical scope of this Commodity. State and local governments procuring under this code appear to include county health departments and state health and human services commissions, though the sample is too small and misaligned to characterize a consistent issuing-body pattern.

The two recent opportunities span Florida and Texas. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, requesting 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries, with a response deadline of July 26, 2023 (a timestamp that appears to be an error in the source record). The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program, a preliminary market-intelligence solicitation without a formal award value or timeline. Neither opportunity aligns clearly with deoxycorticosterone procurement, and the code shows little relevant recent activity for purposes of evaluating pharmaceutical compound demand.